Higher values indicate significant use of equity as currency for inorganic growth, potentially diluting existing shareholders.
This represents the value of common stock issued specifically as consideration for the acquisition of another entity. It...
Common in biotech M&A where equity is used to acquire pipeline assets or technology platforms.
other_issuance_of_common_stock_for_eqrx_acquisition_net__9a4474| FY'21 | FY'22 | FY'23 | FY'24 | FY'25 | |
|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | $1.09B | $0.00 | $0.00 |
| YoY Change | — | — | — | -100.0% | — |